Overview
the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.
Eligibility
inclusion criteria :
- patients with mild to severe unilateral cleft lip requiring repair
- free from any systemic disease
- with or without cleft palate
- fit for general anesthesia exclusion criteria :
- patients with syndromic type of cleft lip
- patients with systemic disease


